ADHERE-S (NIS Brilique)
Study identifier:D5130R00052
ClinicalTrials.gov identifier:NCT03444012
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
non-interventional prospective data collection on persistence and adherence on ticagrelor in ACS adult patients in Serbia
Medical condition
ACS (acute coronary syndrome)
Phase
-
Healthy volunteers
No
Study drug
ticagrelor 90 mg
Sex
All
Actual Enrollment
269
Study type
Observational
Age
18 Years +
Date
Study Start Date: 05 Mar 2018
Primary Completion Date: 13 Aug 2019
Study Completion Date: 13 Aug 2019
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Jul 2020 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
